Livable Lynchburg Wiki

Answered: Your Most Burning Questions About GLP-1: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 January 2026

  • curprev 14:5914:59, 6 January 2026 JannieTietjen74 talk contribs 3,773 bytes +3,773 Created page with "<br> In addition, the GLP-1 mimetic exendin-4 has shown protective effects in a clinical trial in Parkinson's disease (PD) patients. In addition, CRF expression in the PVN is stimulated by central administration of a melanocortin agonist but is inhibited by an MC4R antagonist. In addition, in contrast to non-neural tissues, the desaturation and elongation of palmitate within the brain represents a very minor fate of the fat. Most of the fatty acids within the brain are s..."
Retrieved from "https://wiki.livablelynchburg.org/mediawiki/index.php/Answered:_Your_Most_Burning_Questions_About_GLP-1"